Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Figure 1 | BMC Cell Biology

Figure 1

From: Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes

Figure 1

Hammerhead ribozyme structure and target sequence of the M6P/IGF2R mRNA (A) and ribozyme activity against M6P/IGF2R RNA in vitro (B). 32P-labeled RNA containing the M6P/IGF2R target sequence was incubated with the hammerhead ribozyme and the reaction products were separated by polyacrylamide gel. The ribozyme cleaves the M6P/IGF2R target efficiently and specifically in vitro. Lane 1: Specific target alone; Lane 2: Specific target incubation with ribozyme at time 0; Lane 3–10: Specific target incubation with ribozyme at a time-course of 5, 10, 20, 40, 80, 160, 320 and 640 minutes; Lane11: Unmatched target alone; Lane 12: Unmatched target incubation with ribozyme at 640 minutes.

Back to article page